Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2
The NM_003879.7(CFLAR):c.710A>C(p.Gln237Pro) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 16/26 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
CFLAR (HGNC:1876): (CASP8 and FADD like apoptosis regulator) The protein encoded by this gene is a regulator of apoptosis and is structurally similar to caspase-8. However, the encoded protein lacks caspase activity and appears to be itself cleaved into two peptides by caspase-8. Several transcript variants encoding different isoforms have been found for this gene, and partial evidence for several more variants exists. [provided by RefSeq, Feb 2011]
The c.710A>C (p.Q237P) alteration is located in exon 7 (coding exon 6) of the CFLAR gene. This alteration results from a A to C substitution at nucleotide position 710, causing the glutamine (Q) at amino acid position 237 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Gain of catalytic residue at P236 (P = 0.0107);.;Gain of catalytic residue at P236 (P = 0.0107);Gain of catalytic residue at P236 (P = 0.0107);Gain of catalytic residue at P236 (P = 0.0107);.;.;.;